YatırımMasasıYatırım Masası home
Adam D. Levy, Acrivon Therapeutics stock sale
CFO, SEC Form 4, filed on August 6, 2026
$1,7931,142 shares, average $1.57
- Transaction date
- August 4, 2026
- Shares held after
- 66,008Direct ownership
- Change in holding
- −1.70%From the transactions in the filing
- Filing rows
- 1All open market
Price context
ACRV daily close, Apr 20 to October 26, 2026$2.39$1.38
Daily close
Sale
Trade average $1.57
- Transaction price
- $1.57Weighted average
- Close on trade date
- $1.56August 4, 2026
- Latest close
- $1.72October 26, 2026
- Since the trade
- +9.55%vs the trade average
Transactions in the filing
DateTransactionSecuritySharesPriceAmountAfter
Sale
Common stockDirect
1,142
$1.57
$1,793
66,008
Recent filings at Acrivon Therapeutics
Full historyPersonTransactionAmount or sharesDate